AR034051A1 - Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion - Google Patents

Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Info

Publication number
AR034051A1
AR034051A1 ARP020101999A ARP020101999A AR034051A1 AR 034051 A1 AR034051 A1 AR 034051A1 AR P020101999 A ARP020101999 A AR P020101999A AR P020101999 A ARP020101999 A AR P020101999A AR 034051 A1 AR034051 A1 AR 034051A1
Authority
AR
Argentina
Prior art keywords
compound
halogen
disease
composition
pharmaceutical composition
Prior art date
Application number
ARP020101999A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR034051A1 publication Critical patent/AR034051A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
ARP020101999A 2001-05-31 2002-05-29 Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion AR034051A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113231.5A GB0113231D0 (en) 2001-05-31 2001-05-31 Chemical compounds

Publications (1)

Publication Number Publication Date
AR034051A1 true AR034051A1 (es) 2004-01-21

Family

ID=9915636

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101999A AR034051A1 (es) 2001-05-31 2002-05-29 Compuesto de oxazol o tiazol, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion

Country Status (28)

Country Link
US (1) US7157479B2 (cg-RX-API-DMAC7.html)
EP (1) EP1399430B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004532267A (cg-RX-API-DMAC7.html)
KR (1) KR100859591B1 (cg-RX-API-DMAC7.html)
CN (1) CN1307166C (cg-RX-API-DMAC7.html)
AR (1) AR034051A1 (cg-RX-API-DMAC7.html)
AU (1) AU2002317765B2 (cg-RX-API-DMAC7.html)
BR (1) BR0209785A (cg-RX-API-DMAC7.html)
CA (1) CA2448205A1 (cg-RX-API-DMAC7.html)
CO (1) CO5540297A2 (cg-RX-API-DMAC7.html)
CY (1) CY1107206T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20033252A3 (cg-RX-API-DMAC7.html)
DE (1) DE60223805T2 (cg-RX-API-DMAC7.html)
DK (1) DK1399430T3 (cg-RX-API-DMAC7.html)
ES (1) ES2296965T3 (cg-RX-API-DMAC7.html)
GB (1) GB0113231D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0400043A3 (cg-RX-API-DMAC7.html)
IL (1) IL158929A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03011032A (cg-RX-API-DMAC7.html)
MY (1) MY132656A (cg-RX-API-DMAC7.html)
NO (1) NO20035209L (cg-RX-API-DMAC7.html)
NZ (1) NZ529754A (cg-RX-API-DMAC7.html)
PL (1) PL367248A1 (cg-RX-API-DMAC7.html)
PT (1) PT1399430E (cg-RX-API-DMAC7.html)
SI (1) SI1399430T1 (cg-RX-API-DMAC7.html)
TW (1) TWI245760B (cg-RX-API-DMAC7.html)
WO (1) WO2002096895A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200309095B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04003398A (es) * 2001-10-12 2004-11-22 Nippon Chemiphar Co Activador para el receptor o activado con el proliferador de peroxisoma.
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
GB0314370D0 (en) * 2003-06-19 2003-07-23 Glaxo Group Ltd Chemical compounds
GB0323702D0 (en) * 2003-10-09 2003-11-12 Smithkline Beecham Corp Chemical compound
RU2374230C2 (ru) 2003-11-05 2009-11-27 Ф.Хоффманн-Ля Рош Аг Фенильные производные в качестве ppar агонистов
FR2882359A1 (fr) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S Derives activateurs de ppar, procede de preparation et application en therapeutique
CN101007790B (zh) * 2006-01-27 2011-03-30 北京摩力克科技有限公司 草氨酸衍生物、其制备方法和医药用途
FR2901792A1 (fr) * 2006-06-06 2007-12-07 Negma Lerads Soc Par Actions S DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
JP5357894B2 (ja) * 2008-12-01 2013-12-04 田辺三菱製薬株式会社 チアゾール環を含むカルボン酸誘導体およびその医薬用途
CN110803996B (zh) * 2019-11-13 2022-01-11 台州市创源工业技术有限公司 一种羟基苄胺的合成方法
CN116511225B (zh) * 2023-03-30 2025-09-23 江南大学 一种油酸基des液体及其制备方法和它在厌氧发酵液高效浓缩中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2174121C2 (ru) * 1996-08-19 2001-09-27 Джапан Тобакко Инк. Производные пропионовой кислоты и фармацевтическая композиция на их основе
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
NZ515087A (en) * 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
GB9914977D0 (en) 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
WO2001016120A1 (en) 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2448205A1 (en) 2002-12-05
WO2002096895A1 (en) 2002-12-05
DE60223805D1 (de) 2008-01-10
HUP0400043A2 (hu) 2004-04-28
ES2296965T3 (es) 2008-05-01
US20050070517A1 (en) 2005-03-31
KR20040007632A (ko) 2004-01-24
CO5540297A2 (es) 2005-07-29
HK1064367A1 (en) 2005-01-28
NO20035209L (no) 2004-01-27
AU2002317765B2 (en) 2005-02-03
EP1399430A1 (en) 2004-03-24
CN1307166C (zh) 2007-03-28
GB0113231D0 (en) 2001-07-25
CY1107206T1 (el) 2012-11-21
DE60223805T2 (de) 2008-10-30
JP2004532267A (ja) 2004-10-21
MY132656A (en) 2007-10-31
EP1399430B1 (en) 2007-11-28
CN1633421A (zh) 2005-06-29
CZ20033252A3 (en) 2004-03-17
ZA200309095B (en) 2005-02-21
NO20035209D0 (no) 2003-11-24
TWI245760B (en) 2005-12-21
PL367248A1 (en) 2005-02-21
SI1399430T1 (sl) 2008-04-30
DK1399430T3 (da) 2008-03-25
IL158929A0 (en) 2004-05-12
PT1399430E (pt) 2008-02-19
KR100859591B1 (ko) 2008-09-23
BR0209785A (pt) 2004-06-01
HUP0400043A3 (en) 2008-03-28
US7157479B2 (en) 2007-01-02
MXPA03011032A (es) 2004-03-19
NZ529754A (en) 2005-12-23

Similar Documents

Publication Publication Date Title
PE20011010A1 (es) Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
DE60120217D1 (de) Thia- und oxazole und deren verwendung als ppars-aktivatoren
AR036958A1 (es) Compuestos derivados de pirrolidina, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden y uso de dichos compuestos para la preparacion de medicamentos
PE20091901A1 (es) Activadores de glucoquinasa
AR048377A1 (es) Benzoimidazol-, benzotriazol- y benzoimidazolona - o- glucosidos sustituidos
CO5540299A2 (es) Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas
PE20011022A1 (es) Compuestos trans olefinicos activadores glucoquinasa
TW200608969A (en) Heterocyclic boronic acid compounds
AR048375A1 (es) Indazol-o-glucosidos sustituidos
CO5690638A2 (es) Nuevos compuestos triciclicos utiles para el tratamiento de desordenes inflamatorios y alergicos; proceso para su preparacion y composiciones farmaceuticas que los contienen
PE20030269A1 (es) Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas
TW200510441A (en) Novel compounds
PE20081530A1 (es) Nuevos compuestos 617
PE20021152A1 (es) Derivados de oxazol como agonistas de receptores activados por proliferacion de peroxisoma
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
NO20081821L (no) Forbindelser for behandling av metabolske forstyrrelser
IL182431A0 (en) Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
AR111199A1 (es) Compuesto aromático agonista de gpr40
CR8505A (es) Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
AR040626A1 (es) Derivados de quinolina utiles como ligandos del receptor del neuropeptido y (npy)
AR041395A1 (es) Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla
AR053895A1 (es) Aminopirimidinas como moduladores de quinasas
RU2009114544A (ru) Производные пиридина для лечения метаболических нарушений, связанных с устойчивостью к действию инсулина или гипергликемией
WO2006014262A3 (en) Indoles having anti-diabetic activity
AR053526A1 (es) Derivados del acido alcanoico arilcicloalqui-sustituidos, composicion farmaceutica y procedimiento para su preparacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure